Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics Journal Article


Authors: Ostrom, Q. T.; Egan, K. M.; Nabors, L. B.; Gerke, T.; Thompson, R. C.; Olson, J. J.; LaRocca, R.; Chowdhary, S.; Eckel-Passow, J. E.; Armstrong, G.; Wiencke, J. K.; Bernstein, J. L.; Claus, E. B.; Il'yasova, D.; Johansen, C.; Lachance, D. H.; Lai, R. K.; Merrell, R. T.; Olson, S. H.; Sadetzki, S.; Schildkraut, J. M.; Shete, S.; Houlston, R. S.; Jenkins, R. B.; Wrensch, M. R.; Melin, B.; Amos, C. I.; Huse, J. T.; Barnholtz-Sloan, J. S.; Bondy, M. L.
Article Title: Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics
Abstract: Glioma incidence is highest in non-Hispanic Whites, and to date, glioma genome-wide association studies (GWAS) to date have only included European ancestry (EA) populations. African Americans and Hispanics in the US have varying proportions of EA, African (AA) and Native American ancestries (NAA). It is unknown if identified GWAS loci or increased EA is associated with increased glioma risk. We assessed whether EA was associated with glioma in African Americans and Hispanics. Data were obtained for 832 cases and 675 controls from the Glioma International Case–Control Study and GliomaSE Case–Control Study previously estimated to have <80% EA, or self-identify as non-White. We estimated global and local ancestry using fastStructure and RFMix, respectively, using 1,000 genomes project reference populations. Within groups with ≥40% AA (AFR≥0.4), and ≥15% NAA (AMR≥0.15), genome-wide association between local EA and glioma was evaluated using logistic regression conditioned on global EA for all gliomas. We identified two regions (7q21.11, p = 6.36 × 10−4; 11p11.12, p = 7.0 × 10−4) associated with increased EA, and one associated with decreased EA (20p12.13, p = 0.0026) in AFR≥0.4. In addition, we identified a peak at rs1620291 (p = 4.36 × 10−6) in 7q21.3. Among AMR≥0.15, we found an association between increased EA in one region (12q24.21, p = 8.38 × 10−4), and decreased EA in two regions (8q24.21, p = 0. 0010; 20q13.33, p = 6.36 × 10−4). No other significant associations were identified. This analysis identified an association between glioma and two regions previously identified in EA populations (8q24.21, 20q13.33) and four novel regions (7q21.11, 11p11.12, 12q24.21 and 20p12.13). The identifications of novel association with EA suggest regions to target for future genetic association studies. © 2019 UICC
Keywords: adult; controlled study; middle aged; major clinical study; cancer risk; glioma; disease association; genetic association; genome-wide association study; genome; african american; chromosome 12q; chromosome 20q; chromosome 7q; chromosome 8q; genetic epidemiology; hispanic; chromosome 20p; chromosome 11p; european; ancestry group; human; male; female; priority journal; article; genetic ancestry
Journal Title: International Journal of Cancer
Volume: 146
Issue: 3
ISSN: 0020-7136
Publisher: John Wiley & Sons  
Date Published: 2020-02-01
Start Page: 739
End Page: 748
Language: English
DOI: 10.1002/ijc.32318
PUBMED: 30963577
PROVIDER: scopus
PMCID: PMC6785354
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sara H Olson
    234 Olson
  2. Jonine L Bernstein
    142 Bernstein